Introducing the Youth Entrepreneurship Award finalists

With the EU celebrating the European Year of Skills, AmCham EU and JA Europe are pleased to announce the three finalists for the Youth Entrepreneurship Award 2023. The award, now in its 11th edition, recognises young people’s entrepreneurial spirit and aims to foster innovation in Europe. The finalists were selected from a pool of applicants from all over Europe. The winner will be selected by a high-level jury and announced on Wednesday, 28 June at AmCham EU’s Galaevening. 

News
13 Jun 2023
Introducing the Youth Entrepreneurship Award finalists

The three outstanding finalists are: 

MammoCheck

Entrepreneur: Alexandra Dimitriadou

Country of origin: Cyprus

With MammoCheck, women have a revolutionary tool for early detection of breast cancer in the palm of their hands. Advanced thermography technology combined with artificial intelligence allows women to proactively monitor and detect changes in their breast tissue, leading to better health outcomes and a higher quality of life. With a camera added to one’s phone, anyone can perform painless and accurate breast examinations, giving them the knowledge and awareness, they need to take control of their health.  

Alexandra Dimitriadou is the Chief Executive Officer and Co-founder of MammoCheck.  

 

AMIRA Meditech

Entrepreneur: Natalia Konova

Country of origin: Bulgaria

To fight antimicrobial resistance, AMIRA has developed a software solution to optimise antibiotic prescriptions in hospitals. By monitoring and controlling antibiotic usage, AMIRA helps doctors save time and decreases hospitals' resources. Through one-of-a-kind prediction models and more quickly adapting to the guidelines for treating infections, AMIRA seeks to preserve the effectiveness of antibiotics and save millions of lives. The algorithm is based on latest European and national guidelines for treating infections, as well as the legal documents of the antibiotics and each hospital's unique antibiotic resistance. 

Chief Executive Officer and Co-founder Natalia Konova is a clinical pharmacologist at the Alexandrovska Hospital in Sofia, Bulgaria. She is also currently undertaking a PhD in improving the effectiveness and safety of antibiotics in hospital settings from Sofia’s Medical University’s Department of Pharmacology and Toxicology. 

 

Drug n Drop 

Entrepreneur: Alexia Vasilaki

Country of origin: Greece

Drug n Drop reports and communicates about pharmaceutical waste data along the supply chain to minimise medicinal waste. Through a complete smart system including hardware and software, Drug n Drop aims to optimise the production and management of medicine while managing the environmental and social issues caused by wasted medicines. It is able to produce reports and communicate them to all stakeholders of the pharmaceutical value chain. 

Alexia Vasilaki is Co-founder and Chief Technology Officer of Drug n Drop and is executive assistant to the Chief Executive Officer at Junior Achievement Europe.   

 

Join the conversation on social using #YEA2023

Related items

Publication
25 Jun 2026

Recommendations to the Irish Presidency of the Council of the EU

Ireland will assume the Presidency of the Council of the European Union in the second half of 2026 at a decisive moment for Europe’s competitiveness agenda. With the EU seeking to advance simplification, strengthen the Single Market and shape the next Multiannual Financial Framework, the Presidency will have a critical role to play in turning ambition into action. Its programme spans competitiveness, values and security. However, none of these priorities can succeed without a strong economy that fosters innovation and growth. In this context, AmCham EU’s Recommendations to the Irish Presidency of the Council of the EU sets out concrete actions to advance a competitive and resilient EU economy. These proposals aim to help shape Europe into an attractive place for businesses to invest, operate and grow.

Presidency
Read more
Read more about Recommendations to the Irish Presidency of the Council of the EU
News
24 Jun 2026

A medical milestone, made in Denmark

Pfizer selected Denmark as the site of the largest vaccine registry study ever undertaken, demonstrating how Europe can attract world-leading life sciences investment when the right conditions are in place. Beginning in 2024, Pfizer partnered with researchers at the Center for Translational Cardiology and Pragmatic Randomized Trials at Herlev-Gentofte Hospital in Copenhagen to assess whether its respiratory syncytial virus vaccine could reduce hospitalisations in adults. Denmark’s innovation-friendly environment, national digital mailbox eBoks and world-class health registries enabled researchers to invite almost the entire adult population to take part, helping recruit more than 500,000 participants. Study materials were made available online, allowing participants to provide informed consent from home, while health registries supported comprehensive tracking and analysis. This milestone shows how strong public-private collaboration and a supportive policy framework can help Europe deliver clinical research at scale and improve health outcomes for citizens. Read the full story on Invested in Europe

Healthcare
Read more
Read more about A medical milestone, made in Denmark
Position Paper
22 Jun 2026

Strengthening Ukraine’s integrity architecture for investment

Ukraine’s progress in strengthening the rule of law and building a credible anti-corruption framework in recent years is enhancing its attractiveness as a destination for business and investment. Over the past decade, the establishment of specialised institutions, including NABU, SAPO, the High Anti-Corruption Court and the Prozorro public procurement platform, has improved transparency and enforcement. However, significant challenges remain, including the need to further strengthen judicial independence, ensure the consistent application of reforms and reinforce institutional resilience against political and wartime pressures. While governance risks persist, Ukraine has demonstrated a commitment to reform, supported by EU accession conditionality and international partnerships. Continued progress in these areas will be critical to providing investors with greater legal certainty and confidence in the country’s long-term trajectory.

Experience from the Baltic states illustrates how EU accession can act as a catalyst for institutional transformation, economic growth and increased foreign investment. Ukraine’s reform trajectory reflects many of the same characteristics, suggesting significant long-term potential if current reforms are maintained and deepened. For businesses, successful engagement in Ukraine requires both confidence in the country’s evolving institutional framework and robust internal compliance measures. Continued progress on judicial independence, anti-corruption enforcement and regulatory transparency will be essential to strengthening investor confidence, supporting reconstruction efforts and advancing Ukraine’s integration into the European Union.

Ukraine
Read more
Read more about Strengthening Ukraine’s integrity architecture for investment